Next Generation Sequencing (NGS)

Launch of two NGS panels enables comprehensive detection of genetic abnormalities involved in breast and ovarian cancer, and myeloid disorders

The test can zero in on the microbial cause of infection in as little as six hours—irrespective of what body fluid is sampled

Study finds that beginning with RNA sequencing could increase diagnostic yield by 17 percent

Boosting the efficiency of single-cell RNA-sequencing helps reveal subtle differences between healthy and dysfunctional cells

Patented CRISPRclean™ technology is a foundational tool that improves the performance of next-generation sequencing and other molecular workflows by increasing sensitivity, reducing costs, and enabling novel discovery

TGen and HonorHealth investigators suggest this granular analysis could lead to better treatments for pancreatic cancer patients

As part of an initial pilot focused on oncology, the company is calling for proposals dedicated to gene fusions in solid tumors and molecular testing in blood cancers

Research aims at demonstrating diagnostic value of next-generation sequencing for antimicrobial susceptibility testing and translation into clinical practice

Next-generation sequencing has revolutionized the detection of tumor neoantigens